Edition:
United Kingdom

People: BioTelemetry Inc (BEAT.OQ)

BEAT.OQ on NASDAQ Stock Exchange Global Select Market

46.56USD
18 Jul 2019
Change (% chg)

$-0.87 (-1.83%)
Prev Close
$47.43
Open
$47.34
Day's High
$47.55
Day's Low
$46.51
Volume
133,859
Avg. Vol
170,860
52-wk High
$80.80
52-wk Low
$46.19

Hill, Colin 

Mr. Colin Hill serves as Independent Director of the BioTelemetry Inc. Mr. Hill is a leading voice in healthcare technology and precision medicine and brings impressive leadership experience in commercializing machine learning technologies in the biopharmaceutical and managed care industries. He co-founded GNS Healthcare in 2000 and has since served as Chairman and Chief Executive Officer. Mr. Hill sits on board of PPD, a leading global contract research organization. He is also a founding board member of TMed (Transforming Medicine: The Elizabeth Kauffman Institute), a non-profit foundation (501(c)(3)) dedicated to the advancement of personalized medicine. In 2016, he was appointed by Massachusetts Governor Charlie Baker to the Massachusetts Digital Health Council. Mr. Hill was a founding member of the board of directors of AesRx, a biopharmaceutical company dedicated to the development of new treatments for sickle cell disease (acquired by Baxter in 2014). He was the founding chairman of O’Reilly Media’s Strata Rx in 2012, the first healthcare big data conference in the industry. In 2004, Mr. Hill was named to MIT Technology Review’s TR100 list of the top 100 innovators in the world under the age of 35.

Basic Compensation

Total Annual Compensation, USD 67,500
Restricted Stock Award, USD 130,033
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 197,533

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Kirk Gorman

230,658

Joseph Capper

3,875,560

Heather Getz

1,632,580

Fred Broadway

1,007,410

Peter Ferola

917,995

Daniel Wisniewski

935,098
As Of  31 Dec 2018